Domov › Obézita › Arizona › Phoenix
Klinické štúdie Obézita v meste Phoenix, AZ
22 štúdií pre Obézita hľadá účastníkov v zariadeniach v meste Phoenix a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Early Tracking of Childhood Health Determinants (ETCHED) Study
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- NIDDK, Phoenix, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Prebieha náborFáza 3
- RIO Clinical Trials - Phoenix, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Prebieha náborFáza 3
- Research Site, Phoenix
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Prebieha náborFáza 3
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Prebieha náborFáza 3
- Elite Clinical Studies, LLC, Phoenix
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
Prebieha náborVítaní zdravých dobrovoľníkov
- NIDDK, Phoenix, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Prebieha náborFáza 3
- AURORA-1 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Prebieha náborFáza 3
- AURORA-2 Clinical Site, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Prebieha náborFáza 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Prebieha náborFáza 2
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Prebieha náborFáza 2
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Prebieha náborFáza 4
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Prebieha náborFáza 3
- Kailera Clinical Site, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Prebieha náborFáza 3
- Kailera Clinical Site, Phoenix
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
Prebieha náborVítaní zdravých dobrovoľníkov
- NIDDK, Phoenix, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Prebieha náborObservačná štúdia
- Exponent Phoenix, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Prebieha náborFáza 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Prebieha náborFáza 3
- ACCOMPLISH-1 Research Site, Phoenix
Fibrosis Lessens After Metabolic Surgery
Prebieha náborFáza 4Vítaní zdravých dobrovoľníkov
- Banner Health Center, Phoenix
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Prebieha náborFáza 3
- Arizona Research Center, Inc., Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Prebieha náborFáza 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Štúdie Obézita v iných mestách
- Houston, TX43 štúdií
- Chicago, IL41 štúdií
- New York City, NY40 štúdií
- San Antonio, TX40 štúdií
- Washington, DC33 štúdií
- Orlando, FL31 štúdií
- Dallas, TX30 štúdií
- Boston, MA28 štúdií
- Las Vegas, NV27 štúdií
- Miami, FL27 štúdií
- Baltimore, MD25 štúdií
- Jacksonville, FL25 štúdií
Iné štúdie v Phoenix
- Rakovina prsníka25 štúdií
- Kolorektálny karcinóm25 štúdií
- Nemalobunkový karcinóm pľúc20 štúdií
- Metastatická rakovina20 štúdií
- Srdcové zlyhanie18 štúdií
- Rakovina prostaty17 štúdií
- Rakovina (všetky typy)17 štúdií
- Mnohonásobný myelóm16 štúdií
- Rakovina pankreasu16 štúdií
- Kardiovaskulárne ochorenia16 štúdií
- Alzheimerova choroba15 štúdií
- Nadváha15 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.